Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)?
Dörr
U
U
Dept. Nuclear Medicine, Katharinenhospital, Stuttgart, Germany.
Sautter-Bihl
M L
ML
Schilling
F H
FH
Koscielniak
E
E
Treuner
J
J
Bihl
H
H
D019797:3-Iodobenzylguanidine; D000970:Antineoplastic Agents; D002675:Child, Preschool; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D007223:Infant; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D008297:Male; D009447:Neuroblastoma / Q000000981:diagnostic imaging* / Q000378:metabolism; D015282:Octreotide / Q000031:analogs & derivatives*; D004369:Pentetic Acid / Q000031:analogs & derivatives*; D011003:Ploidies; D011446:Prospective Studies; D011877:Radionuclide Imaging; D017481:Receptors, Somatostatin / Q000235:genetics
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D017481:Receptors, Somatostatin; C071632:SDZ 215-811; D019797:3-Iodobenzylguanidine; D004369:Pentetic Acid; D015282:Octreotide